BTT-369

CAS No. ——

BTT-369( BTT 369 | BTT 369 )

Catalog No. M17024 CAS No. ——

BTT-369 (BTT369) is a voltage-gated CaV2.2 calcium channel inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BTT-369
  • Note
    Research use only, not for human use.
  • Brief Description
    BTT-369 (BTT369) is a voltage-gated CaV2.2 calcium channel inhibitor.
  • Description
    BTT-369 (BTT369) is a voltage-gated CaV2.2 calcium channel inhibitor that disrupts the CaVα·CaVβ3 protein-protein interaction with Ki of 2.0 uM in FP assays; decreases trafficking of CaV2.2 channels to the plasma membrane and modulates the functions of the channel, suppresses pain responses in rodent neuropathic pain models; BTT-369 (BTT369) is a cell-permeable derivative of BTT-266.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BTT 369 | BTT 369
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    580.652
  • Molecular Formula
    C34H28N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (3-(1H-tetrazol-5-yl)phenyl)(5-(4-methoxyphenyl)-1'-phenyl-3'-(p-tolyl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazol]-2-yl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen X, et al. Proc Natl Acad Sci U S A. 2018 Oct 24. pii: 201813157.
molnova catalog
related products
  • Dantrolene sodium he...

    Dantrolene is a postsynaptic muscle relaxant that lessens excitation-contraction coupling in muscle cells.

  • TTA-Q6

    TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.

  • ML335

    ML335 is a selective activator of both TREK-1 and TREK-2.